ArticleTranslational vision science & technology2026
A Structure-Function Dataset With Known Rates of Glaucomatous Progression.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This article describes the Lions Eye Institute Structure-Function Dataset (LEI-SFD), an open, synthetic dataset of both structural and functional measurements from eyes with glaucoma that are progressing at known rates. Methods: The LEI-SFD contains static automated perimetry (SAP) and retinal nerve fiber layer (RNFL) thickness data (circumpapillary RNFL [cpRNFL]) that is progressing at known rates for 10 visits over 5 years. Measurements at the 10th visit and progression rates are taken from curated clinical data collected at Lions Eye Institute, Perth, Australia. Measurement noise is added based on existing literature. Results: The dataset contains 162 eyes with a mean (SD) baseline mean deviation of -2.6 (4.0) dB (minimum, -17.6; maximum, 1.6) and a mean (SD) cpRNFL thickness of 77.7 (13.5) microns (minimum, 43; maximum, 109). The average number of progressing SAP locations per eye is 20.8, with a mean pointwise rate of -0.6 dB/y. Using Permutation of Pointwise Linear Regression (PoPLR) to assess progression on the resulting datasets gives similar classification results to those published on clinical data. Conclusions: This open dataset contains longitudinal, linked structural and functional data with known progression rates. By using visit data and progression rates from real eyes to seed its synthetic generation, relationships between structure and function in current clinical data should be preserved, but with ground-truth progression rates being known. Translational Relevance: This open dataset will allow the assessment of the performance of methods for determining glaucomatous progression that use both structure and function on a common benchmark.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.